A Bayesian approach to estimate the diffusion coefficient of Rhodamine 6G in breast cancer spheroids.
Bayesian inference
Diffusion coefficient
Inverse problem
Markov Chain Monte Carlo
Rhodamine 6G
Spheroid
Journal
Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908
Informations de publication
Date de publication:
10 12 2021
10 12 2021
Historique:
received:
22
05
2021
revised:
10
09
2021
accepted:
04
10
2021
pubmed:
12
10
2021
medline:
25
12
2021
entrez:
11
10
2021
Statut:
ppublish
Résumé
Multicellular spheroids have emerged as a robust platform to model tumor growth and are widely used for studying drug sensitivity. Diffusion is the main mechanism for transporting nutrients and chemotherapeutic drugs into spheroids, since they are typically avascular. In this study, the Bayesian inference was used to solve the inverse problem of determining the light attenuation coefficient and diffusion coefficient of Rhodamine 6G (R6G) in breast cancer spheroids, as a mock drug for the tyrosine kinase inhibitor, Neratinib. Four types of breast cancer spheroids were formed and the diffusion coefficient was estimated assuming a linear relationship between the intensity and concentration. The mathematical model used for prediction is the solution to the diffusion problem in spherical coordinates, accounting for the light attenuation. The Gaussian likelihood was used to account for the error between the measurements and model predictions. The Markov Chain Monte Carlo algorithm (MCMC) was used to sample from the posterior. The posterior predictions for the diffusion and light attenuation coefficients were provided. The results indicate that the diffusion coefficient values do not significantly vary across a HER2+ breast cancer cell line as a function of transglutaminase 2 levels, even in the presence of fibroblast cells. However, we demonstrate that different diffusion coefficient values can be ascertained from tumorigenic compared to nontumorigenic spheroids and from nonmetastatic compared to post-metastatic breast cancer cells using this approach. We also report agreement between spheroid radius, attenuation coefficient, and subsequent diffusion coefficient to give evidence of cell packing in self-assembled spheroids. The methodology presented here will allow researchers to determine diffusion in spheroids to decouple transport and drug penetration changes from biological resistivity.
Identifiants
pubmed: 34634388
pii: S0168-3659(21)00531-9
doi: 10.1016/j.jconrel.2021.10.002
pmc: PMC8671317
mid: NIHMS1752207
pii:
doi:
Substances chimiques
Rhodamines
0
rhodamine 6G
037VRW83CF
Protein Glutamine gamma Glutamyltransferase 2
EC 2.3.2.13
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
60-71Subventions
Organisme : NCI NIH HHS
ID : R00 CA198929
Pays : United States
Informations de copyright
Copyright © 2021. Published by Elsevier B.V.
Références
ACS Biomater Sci Eng. 2018 Dec 10;4(12):4425-4433
pubmed: 33418835
Carbohydr Polym. 2020 Jun 1;237:116124
pubmed: 32241401
J Control Release. 2012 Aug 20;162(1):185-93
pubmed: 22743107
Mol Pharm. 2014 Jul 7;11(7):2071-81
pubmed: 24641346
J Cell Biochem. 2010 Feb 1;109(2):434-46
pubmed: 19950199
Biotechnol Adv. 2016 Dec;34(8):1427-1441
pubmed: 27845258
Tissue Eng Part C Methods. 2016 Mar;22(3):221-49
pubmed: 26650970
Biophys J. 2010 Feb 17;98(4):596-605
pubmed: 20159156
Biomaterials. 2016 Feb;80:106-120
pubmed: 26708088
Bull Exp Biol Med. 2016 Apr;160(6):857-60
pubmed: 27165074
AAPS J. 2013 Jul;15(3):816-31
pubmed: 23605950
Cancer Treat Rev. 2013 May;39(3):219-29
pubmed: 22658319
Mol Cancer Res. 2018 Oct;16(10):1579-1589
pubmed: 29934326
Biomaterials. 2014 Feb;35(7):2264-71
pubmed: 24360576
Soft Matter. 2014 Oct 14;10(38):7480-94
pubmed: 25115846
Cancers (Basel). 2020 May 17;12(5):
pubmed: 32429591
Biophys J. 2005 Dec;89(6):3884-94
pubmed: 16199495
Cancer Res. 2019 Apr 15;79(8):1831-1843
pubmed: 30733195
BMC Syst Biol. 2008 Dec 23;2:110
pubmed: 19105850
Interface Focus. 2020 Apr 6;10(2):20190041
pubmed: 32194929
Lancet Oncol. 2017 Dec;18(12):1688-1700
pubmed: 29146401
Math Biosci. 2018 Sep;303:1-9
pubmed: 29654791
Beilstein J Org Chem. 2012;8:2156-65
pubmed: 23365627
Math Biosci. 2003 Feb;181(2):177-207
pubmed: 12445761
Cancer Treat Rev. 2014 Mar;40(2):259-70
pubmed: 24080156
Cytometry. 1998 Feb 1;31(2):137-45
pubmed: 9482283
Oncogenesis. 2020 Feb 13;9(2):16
pubmed: 32054828
Biomed Opt Express. 2012 Jun 1;3(6):1162-72
pubmed: 22741065
Astrophys J. 2016 Jun 10;824(1):
pubmed: 34776516
J Phys Chem B. 2016 Jul 7;120(26):6120-9
pubmed: 27045770
J Control Release. 2012 Dec 10;164(2):192-204
pubmed: 22613880
Int J Pharm. 2012 Oct 1;435(1):93-7
pubmed: 22326252
Pharmacol Ther. 2016 Jul;163:94-108
pubmed: 27063403
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Biotechnol Bioeng. 1991 Aug 20;38(5):439-46
pubmed: 18604802